Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi-Cheng Huang

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
Acta Cardiologica Sinica|January 29, 2026
Prognostic Implications of Left Ventricular Ejection Fraction Improvement in Patients with Heart Failure with Reduced and Mildly Reduced Ejection FractionYi-Sheng Chen, Chi-Cheng Huang, Chun-Chieh Wang, et al.
The Oncologist|November 23, 2023
Clinical and Genotypic Insights Into Higher Prevalence of Palbociclib Associated Neutropenia in Asian PatientsJiun-I Lai, Ting-Hao Kuo, Kuan-Jung Huang, et al.
BMC Cancer|October 24, 2009
Clinical meaning of age-related expression of fecal cytokeratin 19 in colorectal malignancyChun-Chao Chang, Shung-Haur Yang, Chih-Cheng Chien, et al.
Breast (Edinburgh, Scotland)|August 24, 2024
Estimating the risk of major adverse cardiac events following radiotherapy for left breast cancer using a modified generalized Lyman normal-tissue complication probability modelTzu-Yu Lai, Yu-Wen Hu, Ti-Hao Wang, et al.
International Journal of Molecular Sciences|February 15, 2022
Deciphering Genetic Alterations of Taiwanese Patients with Pancreatic Adenocarcinoma through Targeted SequencingChi-Cheng Huang, Chih-Yi Liu, Chi-Jung Huang, et al.
Clinical and Experimental Medicine|August 12, 2024
Real-world experience with CDK4/6 inhibitors in hormone receptor-positive metastatic and recurrent breast cancer: findings from an Asian populationBo-Fang Chen, Yi-Fang Tsai, Ta-Chung Chao, et al.
Journal of the Chinese Medical Association : JCMA|December 15, 2021
The clinical impacts of molecular subtyping by multigene assay on hormone receptor-positive breast cancersYeng-Ling Liu, Chih-Yi Hsu, Chin-Jung Feng, et al.
Future Oncology (London, England)|October 19, 2021
VGH-TAYLOR: Comprehensive precision medicine study protocol on the heterogeneity of Taiwanese breast cancer patientsChun-Yu Liu, Chi-Cheng Huang, Yi-Fang Tsai, et al.
Cell Adhesion & Migration|February 13, 2019
Small G protein signalling modulator 2 (SGSM2) is involved in oestrogen receptor-positive breast cancer metastasis through enhancement of migratory cell adhesion via interaction with E-cadherinJuo-Han Lin, Wen-Jui Lee, Han-Chung Wu, et al.
Breast Cancer (Tokyo, Japan)|August 27, 2024
Hub metastatic gene signature and risk score of breast cancer patients with small tumor sizes using WGCNAYu-Tien Chang, Zhi-Jie Hong, Hsueh-Han Tsai, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
Acta Cardiologica Sinica|January 29, 2026
Prognostic Implications of Left Ventricular Ejection Fraction Improvement in Patients with Heart Failure with Reduced and Mildly Reduced Ejection FractionYi-Sheng Chen, Chi-Cheng Huang, Chun-Chieh Wang, et al.
The Oncologist|November 23, 2023
Clinical and Genotypic Insights Into Higher Prevalence of Palbociclib Associated Neutropenia in Asian PatientsJiun-I Lai, Ting-Hao Kuo, Kuan-Jung Huang, et al.
BMC Cancer|October 24, 2009
Clinical meaning of age-related expression of fecal cytokeratin 19 in colorectal malignancyChun-Chao Chang, Shung-Haur Yang, Chih-Cheng Chien, et al.
Breast (Edinburgh, Scotland)|August 24, 2024
Estimating the risk of major adverse cardiac events following radiotherapy for left breast cancer using a modified generalized Lyman normal-tissue complication probability modelTzu-Yu Lai, Yu-Wen Hu, Ti-Hao Wang, et al.
International Journal of Molecular Sciences|February 15, 2022
Deciphering Genetic Alterations of Taiwanese Patients with Pancreatic Adenocarcinoma through Targeted SequencingChi-Cheng Huang, Chih-Yi Liu, Chi-Jung Huang, et al.
Clinical and Experimental Medicine|August 12, 2024
Real-world experience with CDK4/6 inhibitors in hormone receptor-positive metastatic and recurrent breast cancer: findings from an Asian populationBo-Fang Chen, Yi-Fang Tsai, Ta-Chung Chao, et al.
Journal of the Chinese Medical Association : JCMA|December 15, 2021
The clinical impacts of molecular subtyping by multigene assay on hormone receptor-positive breast cancersYeng-Ling Liu, Chih-Yi Hsu, Chin-Jung Feng, et al.
Future Oncology (London, England)|October 19, 2021
VGH-TAYLOR: Comprehensive precision medicine study protocol on the heterogeneity of Taiwanese breast cancer patientsChun-Yu Liu, Chi-Cheng Huang, Yi-Fang Tsai, et al.
Cell Adhesion & Migration|February 13, 2019
Small G protein signalling modulator 2 (SGSM2) is involved in oestrogen receptor-positive breast cancer metastasis through enhancement of migratory cell adhesion via interaction with E-cadherinJuo-Han Lin, Wen-Jui Lee, Han-Chung Wu, et al.
Breast Cancer (Tokyo, Japan)|August 27, 2024
Hub metastatic gene signature and risk score of breast cancer patients with small tumor sizes using WGCNAYu-Tien Chang, Zhi-Jie Hong, Hsueh-Han Tsai, et al.
Pageof 15